[Application of PET in radiation oncology].
Positron emission tomography (PET), especially F-18 fluorodeoxyglucose (FDG)-PET, has been recently used to verify the target volume in radiation treatment planning (RTP) for malignancies. The utility of FDG-PET/CT in defining gross tumor volume (GTV) has been shown in many studies, and the target delineation by a fixed threshold of the maximum standardized uptake value (40-50%) is suggested to be useful in RTP for lung cancer, head and neck cancer, etc. But, the spatial resolution, sensitivity, and specificity of PET are not always enough to define the difference between the GTV and the clinical target volume(CTV). Furthermore, FDG-PET is frequently used in the clinical staging before the treatment, and is also applied to the response evaluation after the treatment. This review focuses on the developing applications of PET in radiation oncology.
Hasegawa
Masatoshi
M
Dept. of Radiation Oncology, Nara Medical University, Nara, Japan.
Uto
Fumiaki
F
Asakawa
Isao
I
Kajitani
Chikae
C
Katayama
Emiko
E
Okada
Hiroshi
H
Hontsu
Shigeto
S
Tamamoto
Tetsuro
T
D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000532:radiotherapy*; D049268:Positron-Emission Tomography; D011880:Radiotherapy Planning, Computer-Assisted